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Abstract: 
Background: Ketamine is growing in popularity for procedural sedation in the paediatric population, 
yet safety concerns remain. We performed a retrospective review of practice and outcomes of paedi-
atric ketamine sedation using the World SIVA International Sedation Task Force reporting tool.  
Methods: A retrospective inspection of the dedicated Emergency Department electronic sedation da-
tabase and subsequent note and sedation chart review was performed for all paediatric sedations 
over a 7 year period from September 2006. All adverse events were stratified. 
Results: During the study period a total of 243 paediatric procedural sedations were undertaken, of 
which 215 used ketamine, most commonly for wound management (n=131). The median patient age 
was 4 years (14 months – 15 years). 63.7% were male. 76.7% were discharged home either directly 
(n=101), or following brief observation (n=64). One patient required subsequent General Anaesthetic 
following a failed sedation with paradoxical agitation. 9.8% of patients had an adverse event, the 
most severe risk stratification being “minor risk”. All interventions were “minimal risk”. There were no 
“sentinel risk” outcomes. 
Conclusions: This data supports the on-going use of ketamine for paediatric procedural sedation in 
the Emergency Department by non-anaesthetists. Relatively high resource requirements mean en-
suring adequate numbers may prove challenging.  
 
MESH keywords: Anaesthesia - emergency service;  Anaesthetics i.v. – ketamine; Safety – tech-
niques; Sedation 
 
 
 
 
 
 
 
 
 
 
 
 
  
Introduction: The phencyclidine derivative ketamine has a number of characteristics that make it 
popular for procedural sedation, nowhere more so than in the Emergency Department where other-
wise painful procedures are performed. Unlike other general anaesthetic agents, ketamine causes a 
“dissociative anaesthesia” as a result of a functional dissociation between the cortical and limbic sys-
tems1,2. Due to its relative cardiovascular stability and maintenance of protective airway reflexes2,3 
there has been a gradual increase in its use and popularity as a sedation agent, particularly within 
the paediatric population4. 
 
Historically, paediatric sedation using ketamine was introduced in radiotherapy and burns patients5-7. 
Evidence has subsequently built up supporting its use in the Emergency Department8–16 particularly 
in North America where it is standard practice in many hospitals17-19. By comparison the UK has been 
relatively slow to develop this technique into mainstream practice20-21. The Royal College of Emer-
gency Medicine issued a guideline as early as 2004. The update in 200922 outlined several ad-
vantages including a wide safety margin, avoidance of a general anaesthetic and physical restraint, 
as well as high efficacy. However, like all drugs, ketamine, is not without side effects which include 
respiratory depression, airway compromise, hypersalivation, emesis and emergence phenomena3,4.  
 
The debate around provision of sedation by non-anaesthetists is one that continues23-26. Proponents 
argue that ketamine is fundamentally different and should be treated as such27. Recently, in response 
to disparities in sedation adverse event reporting28, the World Society for Intravenous Anaesthesia 
(World SIVA) developed an adverse event reporting tool29  with the intention of providing outcome 
standardisation and aggregation, with subsequent transparent comparison of adverse sedation prac-
tice outcomes. This has been used in other non-anaesthetist delivered settings30. In light of the avail-
ability of this tool, the on-going debate around non-anaesthetist delivered paediatric sedation, and the 
need for continual scrutiny of our practice we performed a retrospective review of paediatric ketamine 
sedation in our UK-based Emergency Department.  
 
Methods: The Royal Devon and Exeter Hospital Emergency Department has maintained an elec-
tronic database of all procedural sedation undertaken since 2006. This was interrogated to identify all 
paediatric sedations over a 7-year period. A retrospective note review, including the departmental 
ketamine sedation proforma, of those patients identified was performed. Any adverse events identi-
fied were scrutinised using paper and electronic records, and risk stratification performed using the 
World SIVA adverse event reporting tool29. 
 
  
Demographic information was collected, alongside indications, sedation methods and the any ad-
verse events. All data was anonymised, and subsequent statistical analysis performed using Mi-
crosoft Excel (Professional Plus 2010). Statistical significance (p) was placed at 0.05.  In accordance 
with local policy and following completion of the Health Research Authority/Medical Research Council 
decision tree, ethical approval was deemed unnecessary. Incomplete data domains were excluded 
from statistical analysis. 
 
Royal Devon and Exeter Emergency Department has developed a Paediatric Ketamine Procedural 
Sedation Protocol that has evolved over several years, and all sedations were performed according 
to this protocol. The most recent version is shown in Appendix 1. In accordance with this depart-
mental protocol all sedations were performed in the “Resus” area of the department with Emergency 
drugs including suxamethonium, defibrillators and advanced airway equipment available. All patients 
underwent close monitoring using ECG, blood pressure, oxygen saturation and respiratory rate.  Na-
sal capnography was introduced in the department in late 2011 and used routinely therein.  
 
Local guidelines were updated in 2008 to mandate staffing to include at least one sedating doctor  at 
Consultant level, a procedure-tasked operator and nurse. These fulfil obligations set out in UK guide-
lines issued31. 
 
 
Discharge criteria following sedation include pre-procedure ambulation, adverse symptom resolution 
and appropriate supervision. In addition, there must be no injury related reason for on-going observa-
tion or admission.  
 
Results:  From September 2006 to September 2013, a total of 243 paediatric procedural sedations 
were undertaken, of which 215 used ketamine. All non-ketamine sedations were excluded from sub-
sequent analysis but included both inhalational and intravenous techniques (see Table 1). After ket-
amine, the most common technique was nitrous oxide, in isolation (n=9) or in combination with other 
techniques (n=9).  
 
 
 
  
 
Sedation method Number performed 
Ketamine 208 
Ketamine & IN diamorphine 4 
Ketamine & morphine 3 
Nitrous oxide 9 
Nitrous oxide & midazolam 8 
Propofol 3 
Midazolam 2 
Morphine 1 
Propofol & morphine 1 
Propofol & IN diamorphine 1 
Alfentanil & nitrous oxide 1 
Midazolam & morphine 1 
Fentanyl & nitrous oxide 1 
 243 
 
 
Table 1: Methods used for paediatric sedations. Nitrous oxide refers to 70% nitrous oxide, 30% oxygen mix. 
 
The median patient age was 4 years (range 14 months – 15 years). 137 (63.7%) of all patients un-
dergoing ketamine sedation were male. The most common indication for ketamine sedation was 
wound management (n=131), followed by management of fracture and/or dislocation (n=62) (Table 
2). 
Foreign body 19 
Dental procedure 3 
Fracture/dislocation management 62 
Wound management 131 
 
 
Table 2: Indications for paediatric ketamine sedation (n=215)  
 
Intravenous (IV) sedation was used in 187 cases (87.0%), whilst intramuscular (IM) ketamine was 
administered in 28 patients. Median initial dose was 1.25mg/kg IV, and 3.94mg/kg IM. Supplemental 
doses were required in 70 cases – in 34.8% of IV dosed patients and 17.9% IM patients. Supple-
mental doses were given for a prolonged procedure time (n=32) or in response to inadequate seda-
  
tion (n=38). There was no difference between mean initial doses for those patients requiring addi-
tional sedation with intravenous (p=0.07) or intramuscular (p=0.20) administration. Median (mean) 
total doses were 1.65 mg/kg (1.5 mg/kg) IV and 4.63 mg/kg (4 mg/kg).  
 
Over the period examined, with the exception of one year (September 2011-12), there was a de-
crease in the annual number of paediatric ketamine sedations performed. The mean year-on-year 
reduction in numbers performed was 10.9%.  Over the entire study period, 186 sedations (86.5%) 
were performed with at least one Consultant present. Of those performed without documented direct 
consultant involvement, 80% of those were prior to 2008. 
 
Of all patients, 165 (76.7%) were discharged home. This includes 101 who were discharged directly, 
with a further 64 discharged following a brief period of observation. In 2010, a Paediatric Assessment 
Unit (PAU) was introduced from which 25 patients underwent transient post-sedation observation. 
Prior to this, 39 patients were briefly admitted to the General Paediatric ward for observation under 
the care of the duty senior emergency physician prior to discharge. One patient was admitted for 
failed sedation, requiring a subsequent procedure under General Anaesthetic. Forty-nine admissions 
(43.0%) were attributable to the injury itself, and were unrelated to the sedation.  
 
 
Figure 1: Overview of patient destinations. 
 
According to the specified adverse event tool, 21 patients (9.8%) had an “adverse outcome”(Table 3). 
The most common of these were agitation and apnoea. Of all adverse events documented, the most 
severe according to the greatest risk posed were “apnoea” and “desaturation”. These were both clas-
215 paediatric ketamine sedations 
101 discharged directly 
64 observed & 
discharged 
49 injury related 
admission 
1 subsequent GA 
(failed sedation) 
114 admitted 
  
sified as being of “minor risk” as a result of the transient nature of the events. With the exception of 
one paradoxical agitation requiring admission and a subsequent General Anaesthetic, all outcomes 
fell into the “minimal risk” category. All interventions were “minimal risk”, with the single most frequent 
intervention being “none required”. There were no “sentinel risk” (i.e. critical enough to represent real 
or serious imminent risk of serious and major patient injury) descriptors, interventions or outcomes 
over the 7 year period.  
Adverse Events Minimal risk descriptors Minor risk descriptors 
Recovery agitation 4 0 
Apnoea (not prolonged, <60s) 0 4 
Paradoxical response 1 0 
Desaturation (75-90%, <60s) 0 2 
Failed IV access 3 0 
Rash 3 0 
Vomiting/retching 3 0 
Hypersalivation 1 0 
Interventions Minimal risk intervention  
  
Minor risk intervention 
Supplemental oxygen, new or increased 4 0 
Airway repositioning 5 0 
Tactile stimulation 1 0 
None required 11 0 
Outcome Minimal risk outcome Moderate risk outcome 
 20 1 
 
 
Discussion: We have demonstrated that the paediatric procedural ketamine sedation appears safe 
in our department. Over a 7-year period there were no major or sentinel adverse events or outcomes 
in 215 consecutive children. This is the first time the World SIVA adverse event tool29 has been used 
for paediatric ketamine sedation, although the tool has been used elsewhere in both adults, and chil-
dren26, 30, 32-36. There are many advantages to using an internationally recognised sedation reporting 
tool, including the standardisation of terminology of adverse events, and allowing ease of comparison 
between different centres. There are other paediatric sedation tools available37, however we found 
applying the World SIVA tool retrospectively straightforward.   
 
One advantage of this tool is that it clearly categorises events and outcomes (Table 2) for subse-
quent analysis. In this case series, the most severe events were both categorised as minor risk de-
scriptors and were “apnoea (not prolonged, <60 s)” and “oxygen desaturation (75-90%, <60 s)”. One 
episode of desaturation was due to partial airway obstruction, and the other was a probable meas-
  
urement error with a documented rapid “jump” to normal values. The interventions were also deemed 
“minimal risk”. It is worth noting that the majority of adverse effects demonstrated were recognised 
side-effects of ketamine itself.  
 
No drug is without side-effects and ketamine is no exception. Experience from North America has 
identified a number of predictors of airway complications including age (< 2 years, > 13 years), high-
doses and co-administration of anticholinergics or benzodiazepines38. Similarly, patterns of post-
emergence agitation and emesis have been identified39. The encompassing nature of the World SIVA 
tool means that many recognised side-effects of ketamine such as vomiting or hypersalivation are 
included in the 9.8% overall adverse event rate. It is a therefore a strength of this tool that it can dif-
ferentiate the degrees of severity of events.  
 
Over the time period of this study, our Emergency Department admissions increased by over 30%. It 
is perhaps surprising therefore, that over the same time period numbers of paediatric ketamine seda-
tions decreased by a mean 10.9% per year. As with any procedure, maintaining patient safety is par-
amount and because of the necessary patient safety precautions, procedural sedation is “resource 
heavy” in its requirements for senior staff and a “Resus” bay for appropriate monitoring31. With in-
creasing pressures on Emergency Departments, it may be that providing this service becomes more 
challenging. 
 
It has been argued that the differing mechanism, clinical effects and safety profile of ketamine mean 
traditional definitions and sedation scales are inappropriate27. Furthermore, the lack of a defined 
dose-response continuum has led to the definition of dissociative sedation as achieving profound an-
algesia and amnesia, with retention of protective airway reflexes, spontaneous respirations, and car-
diopulmonary stability”27. In the context of this definition, it is arguable that those patients requiring 
simple airway manipulation and becoming apnoeic were receiving general anaesthesia.  
 
The decreasing numbers of paediatric sedations performed raises an interesting dilemma regarding 
maintenance of skills. When a sedation goes unremarkably - as the vast majority of these did, there 
is little testing of the robustness of the rescue systems that are in place. It is when adverse events of 
an escalating severity occur that the systems are truly tested. In a review of 95 adverse paediatric 
sedation events (including 51 deaths), it was noted that severe complications are most often attribut-
able to the skills of the practitioner in failing to rescue the patient40. This is not a new phenomenon41, 
  
and it has been argued that paediatric sedation outside large centres may result in poorer out-
comes42. However this data suggests that this may not be the case providing that on-going training 
and continuous reviewing of practice occurs amidst a robust clinical governance strategy. For exam-
ple, our current departmental strategy includes annual review of cases and physician caseload, an 
annual workshop on laryngospasm with senior anaesthetist input, and having the management of 
laryngospasm embedded within the ketamine sedation chart 
 
The same adverse events review noted physician type was unrelated to complications – and certainly 
this is an opinion that has been raised vociferously elsewhere43. It has been argued that dividing pro-
viders into anaesthetist/non-anaesthetist subgroups does not account for the discrepancies in skills 
and training, and that instead studies regarding complications should be stratified by skill level and 
competency to ensure rigorous safety standards42. A recent review of our Emergency Department 
adult propofol sedation practice30, and the debate that ensued, demonstrates the variety in ac-
ceptance and perceptions of emergency physician delivered sedation23-25,44,45. 
 
Some anaesthetists will be more comfortable providing a General Anaesthetic46 for the paediatric 
population than sedation. By contrast, Emergency Physicians may be more frequently exposed to 
and potentially be more comfortable performing paediatric sedation. 
 
In children undergoing MRI and CT, it has been demonstrated that a General Anaesthetic provides 
better image quality and an improved safety profile47. Nonetheless, to our knowledge no direct com-
parison studies in terms of safety or satisfaction, comparing General Anaesthetic with sedation, have 
been performed in the Emergency Department setting.  
 
Our results showed that 76.7% of patients were discharged home following a period of supervised 
recovery either within the Emergency Department, the PAU or the paediatric ward. Only one patient 
had a sedation that failed due to paradoxical agitation, requiring a subsequent General Anaesthetic. 
The remainder of patients admitted were done so for definitive management of their original injury fol-
lowing initial management performed under sedation. This overall equates to a total of 165 avoided 
General Anaesthetics – a clear reduction of pressure on both theatre and anaesthetic services. In 
addition, there are other advantages such as reducing admission times and minimising further disrup-
tion to the lives of the parents and families.  
 
  
These results are limited by the fact they are from a single institution and are based upon a retro-
spective chart/notes review, from which extrapolating quantitative data can be “fraught with error”48. 
However, the majority of reported outcomes such as complications and discharge outcomes are 
clear-cut and there was very limited abstraction or room for interpretation.  Similar methods have 
been used previously in a multi-centre study to demonstrate that ketamine procedural sedation pro-
vides a faster turnaround time in paediatric radial fractures when compared to a general anaesthet-
ic49. This faster discharge time has benefits for both child and family in terms of minimising disruption 
and loss of earnings.  
 
We have demonstrated that an emergency department paediatric ketamine sedation programme can 
be delivered safely in a UK non-specialist tertiary paediatric centre. This will be no surprise to many 
given the established safety profile of paediatric ketamine sedation elsewhere8-21. However, with in-
creasing pressures on departments, maintaining safety standards is paramount.  Sufficient numbers 
of procedures must be performed to maintain skills and procedural familiarity, and as such efforts 
need to be made to ensure procedural sedation continues to be done in a safe and timely manner – 
and in sufficient numbers to ensure continued safety of this valuable service that benefits children 
and their families.  
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